RAMP FLU A+B

Faster results for better patient management

The Challenge

CLASSIC MICROBIOLOGY TESTING IS SLOW

  • The World Health Organization (WHO) estimates that annual influenza (“flu”) epidemics result in about 3 to 5 million cases of severe illness, and about 290,000 to 650,000 respiratory deaths.
  • Laboratory testing is necessary to differentiate flu from other viruses that can cause influenza-like illness (ILI).
  • Traditional viral culture techniques can take up to 72 hours
  • Rapid visual tests can be subjective, and their reliability depends on the conditions under which they are used.
, RAMP FLU A+B, Response Biomedical

The Solution

, RAMP FLU A+B, Response Biomedical

TEST PRINCIPLES

  • Differentiates between influenza A and B
  • Sample Medium: nasal wash/aspirate, nasopharyngeal aspirate and nasopharyngeal swab
  • Fluorescent immunoassay with anti-influenza A and anti-influenza B antibodies bind to influenza A or B nucleoprotein antigens, respectively (if present in the sample)
  • Proprietary RAMP® buffer enhances performance
  • A calibrated transfer device is provided with every kit
  • For use with RAMP® 200 only
  • RAMP Flu A+B

    • Aids in the rapid differential diagnosis of influenza viral infections in symptomatic patients.
    • Identifies the presence  of influenza A and influenza B nucleoprotein antigens in nasal wash/aspirate, nasopharyngeal swab or nasopharyngeal aspirate specimens.
    • Objective, qualitative results in ~15 minutes
    • Instrument-based data capture and LIS connectivity

    Additional Information

    24 Hour Technical Support Available for all RAMP Customers

    Contact Our Specialists

    For Any Inquiries

    QUICK QUOTE

    Share on linkedin
    Share on facebook
    Share on google
    Share on twitter
    Share on email

    Share this page

    Share on linkedin
    LinkedIn
    Share on facebook
    Facebook
    Share on twitter
    Twitter
    Share on email
    Email